Uhlir, Victoria
Stallmach, Andreas
Grunert, Philip Christian
Funding for this research was provided by:
Universitätsklinikum Jena
Article History
Received: 12 March 2023
Accepted: 25 July 2023
First Online: 22 August 2023
Declarations
:
: Ethical approval was granted by the Ethics Committee of the Jena University Hospital, Jena, Germany (5530–05/18), and all patients provided signed informed consent for participation in the study, according to the Declaration of Helsinki.
: Not applicable.
: VU reports no competing interests. AS reports research funding from AbbVie and Celltrion and has received lecture fees from AbbVie, Amgen, Astellas, Biogen, Celltrion, Institut Allergosan, Janssen, Falk Foundation, Ferring, MSD, Recordati Pharma, Streamed-Up, and Takeda, and consulting fees from AbbVie, Astellas, Amgen, Biogen, CLS Behring, Consal, Galapagos, Hexal, Janssen, MSD, Norgine, Pfizer Pharma, Takeda, Pharmacosmos, and Tillots Pharma. PCG obtained consulting fees from Janssen and Takeda and lecture fees and from AbbVie, Janssen, Pfizer, Falk, and Takeda.